NCT01697163View on ClinicalTrials.gov

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

UnknownOBSERVATIONAL

Enrollment

155

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

NSCLC

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Severance Hospital

OTHER